AzTrials
AzTrials

AnesthesiaNCT03399201

The Effect of Anesthesia Type on Pulmonary Function

A study testing General anesthesia, Neuraxial anesthesia and Spirometer in people with Anesthesia and Geriatric Patients, run by Tokat Gaziosmanpasa University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The role of neuraxial anesthesia in preventing respiratory complications is a controversial in elderly patients. The aim of the study was to evaluate the benefits of neuraxial anesthesia on pulmonary function during post-operative term in geriatric patients undergoing to elective non-abdominal surgery. Read more about this study

Who is it for?
Ages 65 to 95 years
Conditions the study is for
Anesthesia, Geriatric Patients
What is being tested?
General anesthesia, Neuraxial anesthesia and Spirometer
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
16 Feb 2018to 2 Dec 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 95 years
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • 65 years of age
  • Undergoing non-abdominal surgery under anesthesia in supine position

Who cannot join

  • Pulmonary disease
  • Hematological disease
  • Undergoing Abdominal surgery
  • Non-supine position during surgery
  • Nicotine Abuse

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Gaziosmanpasa University Hospital

    Tokat Province, Merkez, 60100

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of General or Spinal Anesthesia on Pulmonary Function Tests in Geriatric Patients

The role of neuraxial anesthesia in preventing respiratory complications is a controversial in elderly patients. The aim of the study was to evaluate the benefits of neuraxial anesthesia on pulmonary function during post-operative term in geriatric patients undergoing to elective non-abdominal surgery.

Read the detailed description

Sixty elder patients will be randomly assigned to General anesthesia or Neuraxial anesthesia groups. Spirometry, will be performed at pre-operative and post-operative terms. Pulmonary function tests will be evaluated.

Being tested
General anesthesia, Neuraxial anesthesia, Spirometer

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • General anesthesiaProcedure or surgery

    induction with the intravenous anesthetic (Propofol) and maintenance with the inhalational anesthetic (Sevoflurane)

  • Neuraxial anesthesiaProcedure or surgery

    Spinal anesthesia will be applied via the local anesthetic ( Bupivacaine).

  • SpirometerDiagnostic test

    Pulmonary function will be evaluated via the portable spirometer (MIR Spirodoc, Spirodoc®, Roma, Italy)

Study groups in NCT03399201
Study groupRoleWhat they receive
General AnesthesiaActive comparatorStandard General Anesthesia will be applied.The change of the pulmonary functions will be evaluated via spirometer.
Receives: Procedure: General anesthesia; Diagnostic Test: Spirometer
Neuraxial AnesthesiaActive comparatorNeuraxial anesthesia will be applied. The change of the pulmonary functions will be evaluated via spirometer.
Receives: Procedure: Neuraxial anesthesia; Diagnostic Test: Spirometer

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The changes on forced vital capacity

    Forced vital capacity will be measured via spirometer

    Measured: At Preoperative, postoperative 2. hours, postoperative 24. hours

  2. The changes on forced expiratory volume in 1 s

    Forced expiratory volume in 1 s will be measured via spirometer

    Measured: At Preoperative, postoperative 2. hours, postoperative 24. hours

  3. The changes on mid-expiratory flow (MEF 25-75)

    mid-expiratory flow (MEF 25-75) will be measured via spirometer

    Measured: At Preoperative, postoperative 2. hours, postoperative 24. hours

  4. The changes on peak expiratory flow (PEF)

    Peak expiratory flow (PEF) will be measured by the spirometer

    Measured: At Preoperative, postoperative 2. hours, postoperative 24. hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jan 2018
  2. Study start16 Feb 2018
  3. Primary completion2 Dec 2018
  4. Study completion2 Dec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03399201
Sponsor's protocol ID
Spiro
Status last verified
Dec 2018
First submitted
22 Dec 2017
Last updated
19 Dec 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing General anesthesia, Neuraxial anesthesia and Spirometer in people with Anesthesia and Geriatric Patients, run by Tokat Gaziosmanpasa University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Dec 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The changes on forced vital capacity (time frame: At Preoperative, postoperative 2. hours, postoperative 24. hours). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Dec 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in